Aragen Life Sciences IPO: Company files DRHP with SEBI for ₹800 crore fresh issue and OFS of up to 27.33 million equity shares.
Read MoreCDMO
OneSource Specialty Pharma to Manufacture Biosimilars for Formycon AG Under Strategic Partnership
OneSource Specialty Pharma partners with Formycon AG to provide integrated biologics manufacturing for biosimilars, supporting global healthcare markets.
Read More